Maravai Lifesciences Holdings 

Yahoo Finance • 18 days ago

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

Maravai LifeSciences Holdings LLC SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to an... Full story

Yahoo Finance • 2 months ago

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more LELAND, N.C. & SAN DIEGO, August 28, 2024--(BUSINESS WIRE)--Cygnus... Full story

Yahoo Finance • 6 months ago

Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Maravai LifeSciences Holdings (NASDAQ:MRVI) First Quarter 2024 Results Key Financial Results Revenue: US$64.2m (down 19% from 1Q 2023). Net loss: US$12.1m (loss widened by US$12.0m from 1Q 2023). US$0.091 loss per share (further deterior... Full story

Yahoo Finance • 8 months ago

Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call

Participants Andrew Burch; President of Nucleic Acid Production; Maravai LifeSciences Holdings, Inc. Debra Hart; Senior Director of IR; Maravai LifeSciences Holdings, Inc. Kevin M. Herde; Executive VP & CFO; Maravai LifeSciences Holding... Full story

Yahoo Finance • 9 months ago

Will Maravai LifeSciences Holdings (MRVI) Pipeline Start to Bear Fruit?

Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In 2023, the fund (Institutional Shares) returned 22.58% outperforming the 1... Full story

Yahoo Finance • 12 months ago

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor... Full story

Yahoo Finance • 12 months ago

Maravai LifeSciences Holdings Inc (MRVI) Reports Q3 2023 Financial Results Amidst Market Realignment

Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) reports a significant year-over-year revenue decrease in Q3 2023. The company announces a workforce reduction and cost realignment to improve operational efficiencies. Updated financial guida... Full story

Yahoo Finance • last year

12 Cheap Biotech Stocks Smart Investors Are Piling Into

In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into. If you want to skip our introduction to the biotechnology industry and how it might be affected by recent economic and stock market t... Full story

Yahoo Finance • last year

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023

SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2023 fin... Full story

Yahoo Finance • last year

Maravai LifeSciences Hosts 2023 Investor R&D Day

SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, hosted its 2023... Full story

Yahoo Finance • last year

Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100

SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Chief Innovation Officer Kate Br... Full story

Yahoo Finance • last year

Maravai LifeSciences to Host 2023 Investor R&D Day

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 20... Full story

Yahoo Finance • last year

Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit

LELAND, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characterization of process-related impurities in... Full story

Yahoo Finance • last year

TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog

SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its newest cap analog, CleanCap® M6 . Th... Full story

Yahoo Finance • 2 years ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023

SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2023 fi... Full story

Yahoo Finance • 2 years ago

Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report

- Highlights progress across five priority areas focused on building a foundation for sustainable growth. - Reports Scope 1 and Scope 2 greenhouse gas emissions. - Maravai advances Diversity, Equity & Inclusion and has an executive leade... Full story

Yahoo Finance • 2 years ago

Maravai LifeSciences Announces March 2023 Investor Conference Schedule

SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor... Full story

Yahoo Finance • 2 years ago

13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds

In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. According... Full story

Yahoo Finance • 2 years ago

Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results

Base business revenues, excluding COVID-19 related CleanCap® revenues, were up 67% in the fourth quarter and up 17% for the full year Announces acquisition of privately-held Alphazyme, LLC, adding critical enzyme manufacturing capabilitie... Full story

Yahoo Finance • 2 years ago

Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023

SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and ful... Full story